SGLT2 inhibitors and haemoglobin increase: a possible explanation of the cardiovascular benefits?
Home | Video pages | Webcast | The role of complement in glomerulonephritis: are novel therapies ready for prime time?
SGLT2 inhibitors and haemoglobin increase: a possible explanation of the cardiovascular benefits?
Low dialysate sodium and 48-h ambulatory blood pressure in patients with intradialytic hypertension: a randomized crossover study